Global Exosome Therapy Market Growth (Status and Outlook) 2023-2029

February 2023 | 102 pages | ID: GA4CB7757076EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

LPI (LP Information)' newest research report, the “Exosome Therapy Industry Forecast” looks at past sales and reviews total world Exosome Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapy sales for 2023 through 2029. With Exosome Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapy industry.

This Insight Report provides a comprehensive analysis of the global Exosome Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Exosome Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapy.

The global Exosome Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Exosome Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Exosome Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Exosome Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Exosome Therapy players cover United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals and AEGLE Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Direct Treatment
• Drug Delivery Vehicle

Segmentation by application

• Hospital
• Clinic
• Research Institutions

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• United Therapeutics Corporation
• Codiak BioSciences
• EngEx™
• Esperite Group
• ArunA Biomedical
• Evox Therapeutics
• NeurExo Sciences
• Tavec Pharmaceuticals
• AEGLE Therapeutics
• Avalon GloboCare
• AlligatorBioscience
• Capricor Therapeutics
• Stem Cell Medicine
• CellTex Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Exosome Therapy Market Size 2018-2029
  2.1.2 Exosome Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Exosome Therapy Segment by Type
  2.2.1 Direct Treatment
  2.2.2 Drug Delivery Vehicle
2.3 Exosome Therapy Market Size by Type
  2.3.1 Exosome Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Exosome Therapy Market Size Market Share by Type (2018-2023)
2.4 Exosome Therapy Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research Institutions
2.5 Exosome Therapy Market Size by Application
  2.5.1 Exosome Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Exosome Therapy Market Size Market Share by Application (2018-2023)

3 EXOSOME THERAPY MARKET SIZE BY PLAYER

3.1 Exosome Therapy Market Size Market Share by Players
  3.1.1 Global Exosome Therapy Revenue by Players (2018-2023)
  3.1.2 Global Exosome Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Exosome Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EXOSOME THERAPY BY REGIONS

4.1 Exosome Therapy Market Size by Regions (2018-2023)
4.2 Americas Exosome Therapy Market Size Growth (2018-2023)
4.3 APAC Exosome Therapy Market Size Growth (2018-2023)
4.4 Europe Exosome Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Exosome Therapy Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Exosome Therapy Market Size by Country (2018-2023)
5.2 Americas Exosome Therapy Market Size by Type (2018-2023)
5.3 Americas Exosome Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Exosome Therapy Market Size by Region (2018-2023)
6.2 APAC Exosome Therapy Market Size by Type (2018-2023)
6.3 APAC Exosome Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Exosome Therapy by Country (2018-2023)
7.2 Europe Exosome Therapy Market Size by Type (2018-2023)
7.3 Europe Exosome Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Exosome Therapy by Region (2018-2023)
8.2 Middle East & Africa Exosome Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Exosome Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EXOSOME THERAPY MARKET FORECAST

10.1 Global Exosome Therapy Forecast by Regions (2024-2029)
  10.1.1 Global Exosome Therapy Forecast by Regions (2024-2029)
  10.1.2 Americas Exosome Therapy Forecast
  10.1.3 APAC Exosome Therapy Forecast
  10.1.4 Europe Exosome Therapy Forecast
  10.1.5 Middle East & Africa Exosome Therapy Forecast
10.2 Americas Exosome Therapy Forecast by Country (2024-2029)
  10.2.1 United States Exosome Therapy Market Forecast
  10.2.2 Canada Exosome Therapy Market Forecast
  10.2.3 Mexico Exosome Therapy Market Forecast
  10.2.4 Brazil Exosome Therapy Market Forecast
10.3 APAC Exosome Therapy Forecast by Region (2024-2029)
  10.3.1 China Exosome Therapy Market Forecast
  10.3.2 Japan Exosome Therapy Market Forecast
  10.3.3 Korea Exosome Therapy Market Forecast
  10.3.4 Southeast Asia Exosome Therapy Market Forecast
  10.3.5 India Exosome Therapy Market Forecast
  10.3.6 Australia Exosome Therapy Market Forecast
10.4 Europe Exosome Therapy Forecast by Country (2024-2029)
  10.4.1 Germany Exosome Therapy Market Forecast
  10.4.2 France Exosome Therapy Market Forecast
  10.4.3 UK Exosome Therapy Market Forecast
  10.4.4 Italy Exosome Therapy Market Forecast
  10.4.5 Russia Exosome Therapy Market Forecast
10.5 Middle East & Africa Exosome Therapy Forecast by Region (2024-2029)
  10.5.1 Egypt Exosome Therapy Market Forecast
  10.5.2 South Africa Exosome Therapy Market Forecast
  10.5.3 Israel Exosome Therapy Market Forecast
  10.5.4 Turkey Exosome Therapy Market Forecast
  10.5.5 GCC Countries Exosome Therapy Market Forecast
10.6 Global Exosome Therapy Forecast by Type (2024-2029)
10.7 Global Exosome Therapy Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 United Therapeutics Corporation
  11.1.1 United Therapeutics Corporation Company Information
  11.1.2 United Therapeutics Corporation Exosome Therapy Product Offered
  11.1.3 United Therapeutics Corporation Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 United Therapeutics Corporation Main Business Overview
  11.1.5 United Therapeutics Corporation Latest Developments
11.2 Codiak BioSciences
  11.2.1 Codiak BioSciences Company Information
  11.2.2 Codiak BioSciences Exosome Therapy Product Offered
  11.2.3 Codiak BioSciences Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Codiak BioSciences Main Business Overview
  11.2.5 Codiak BioSciences Latest Developments
11.3 EngEx™
  11.3.1 EngEx™ Company Information
  11.3.2 EngEx™ Exosome Therapy Product Offered
  11.3.3 EngEx™ Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 EngEx™ Main Business Overview
  11.3.5 EngEx™ Latest Developments
11.4 Esperite Group
  11.4.1 Esperite Group Company Information
  11.4.2 Esperite Group Exosome Therapy Product Offered
  11.4.3 Esperite Group Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Esperite Group Main Business Overview
  11.4.5 Esperite Group Latest Developments
11.5 ArunA Biomedical
  11.5.1 ArunA Biomedical Company Information
  11.5.2 ArunA Biomedical Exosome Therapy Product Offered
  11.5.3 ArunA Biomedical Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 ArunA Biomedical Main Business Overview
  11.5.5 ArunA Biomedical Latest Developments
11.6 Evox Therapeutics
  11.6.1 Evox Therapeutics Company Information
  11.6.2 Evox Therapeutics Exosome Therapy Product Offered
  11.6.3 Evox Therapeutics Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Evox Therapeutics Main Business Overview
  11.6.5 Evox Therapeutics Latest Developments
11.7 NeurExo Sciences
  11.7.1 NeurExo Sciences Company Information
  11.7.2 NeurExo Sciences Exosome Therapy Product Offered
  11.7.3 NeurExo Sciences Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 NeurExo Sciences Main Business Overview
  11.7.5 NeurExo Sciences Latest Developments
11.8 Tavec Pharmaceuticals
  11.8.1 Tavec Pharmaceuticals Company Information
  11.8.2 Tavec Pharmaceuticals Exosome Therapy Product Offered
  11.8.3 Tavec Pharmaceuticals Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Tavec Pharmaceuticals Main Business Overview
  11.8.5 Tavec Pharmaceuticals Latest Developments
11.9 AEGLE Therapeutics
  11.9.1 AEGLE Therapeutics Company Information
  11.9.2 AEGLE Therapeutics Exosome Therapy Product Offered
  11.9.3 AEGLE Therapeutics Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 AEGLE Therapeutics Main Business Overview
  11.9.5 AEGLE Therapeutics Latest Developments
11.10 Avalon GloboCare
  11.10.1 Avalon GloboCare Company Information
  11.10.2 Avalon GloboCare Exosome Therapy Product Offered
  11.10.3 Avalon GloboCare Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Avalon GloboCare Main Business Overview
  11.10.5 Avalon GloboCare Latest Developments
11.11 AlligatorBioscience
  11.11.1 AlligatorBioscience Company Information
  11.11.2 AlligatorBioscience Exosome Therapy Product Offered
  11.11.3 AlligatorBioscience Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 AlligatorBioscience Main Business Overview
  11.11.5 AlligatorBioscience Latest Developments
11.12 Capricor Therapeutics
  11.12.1 Capricor Therapeutics Company Information
  11.12.2 Capricor Therapeutics Exosome Therapy Product Offered
  11.12.3 Capricor Therapeutics Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Capricor Therapeutics Main Business Overview
  11.12.5 Capricor Therapeutics Latest Developments
11.13 Stem Cell Medicine
  11.13.1 Stem Cell Medicine Company Information
  11.13.2 Stem Cell Medicine Exosome Therapy Product Offered
  11.13.3 Stem Cell Medicine Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Stem Cell Medicine Main Business Overview
  11.13.5 Stem Cell Medicine Latest Developments
11.14 CellTex Therapeutics
  11.14.1 CellTex Therapeutics Company Information
  11.14.2 CellTex Therapeutics Exosome Therapy Product Offered
  11.14.3 CellTex Therapeutics Exosome Therapy Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 CellTex Therapeutics Main Business Overview
  11.14.5 CellTex Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Exosome Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Direct Treatment
Table 3. Major Players of Drug Delivery Vehicle
Table 4. Exosome Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Exosome Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Exosome Therapy Market Size Market Share by Type (2018-2023)
Table 7. Exosome Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Exosome Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Exosome Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Exosome Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Exosome Therapy Revenue Market Share by Player (2018-2023)
Table 12. Exosome Therapy Key Players Head office and Products Offered
Table 13. Exosome Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Exosome Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Exosome Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Exosome Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Exosome Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Exosome Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Exosome Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Exosome Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Exosome Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Exosome Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Exosome Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Exosome Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Exosome Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Exosome Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Exosome Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Exosome Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Exosome Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Exosome Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Exosome Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Exosome Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Exosome Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Exosome Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Exosome Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Exosome Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Exosome Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Exosome Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Exosome Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Exosome Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Exosome Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Exosome Therapy
Table 45. Key Market Challenges & Risks of Exosome Therapy
Table 46. Key Industry Trends of Exosome Therapy
Table 47. Global Exosome Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Exosome Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Exosome Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Exosome Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. United Therapeutics Corporation Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 52. United Therapeutics Corporation Exosome Therapy Product Offered
Table 53. United Therapeutics Corporation Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. United Therapeutics Corporation Main Business
Table 55. United Therapeutics Corporation Latest Developments
Table 56. Codiak BioSciences Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 57. Codiak BioSciences Exosome Therapy Product Offered
Table 58. Codiak BioSciences Main Business
Table 59. Codiak BioSciences Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Codiak BioSciences Latest Developments
Table 61. EngEx™ Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 62. EngEx™ Exosome Therapy Product Offered
Table 63. EngEx™ Main Business
Table 64. EngEx™ Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. EngEx™ Latest Developments
Table 66. Esperite Group Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 67. Esperite Group Exosome Therapy Product Offered
Table 68. Esperite Group Main Business
Table 69. Esperite Group Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Esperite Group Latest Developments
Table 71. ArunA Biomedical Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 72. ArunA Biomedical Exosome Therapy Product Offered
Table 73. ArunA Biomedical Main Business
Table 74. ArunA Biomedical Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. ArunA Biomedical Latest Developments
Table 76. Evox Therapeutics Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 77. Evox Therapeutics Exosome Therapy Product Offered
Table 78. Evox Therapeutics Main Business
Table 79. Evox Therapeutics Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Evox Therapeutics Latest Developments
Table 81. NeurExo Sciences Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 82. NeurExo Sciences Exosome Therapy Product Offered
Table 83. NeurExo Sciences Main Business
Table 84. NeurExo Sciences Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. NeurExo Sciences Latest Developments
Table 86. Tavec Pharmaceuticals Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 87. Tavec Pharmaceuticals Exosome Therapy Product Offered
Table 88. Tavec Pharmaceuticals Main Business
Table 89. Tavec Pharmaceuticals Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Tavec Pharmaceuticals Latest Developments
Table 91. AEGLE Therapeutics Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 92. AEGLE Therapeutics Exosome Therapy Product Offered
Table 93. AEGLE Therapeutics Main Business
Table 94. AEGLE Therapeutics Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. AEGLE Therapeutics Latest Developments
Table 96. Avalon GloboCare Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 97. Avalon GloboCare Exosome Therapy Product Offered
Table 98. Avalon GloboCare Main Business
Table 99. Avalon GloboCare Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Avalon GloboCare Latest Developments
Table 101. AlligatorBioscience Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 102. AlligatorBioscience Exosome Therapy Product Offered
Table 103. AlligatorBioscience Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AlligatorBioscience Main Business
Table 105. AlligatorBioscience Latest Developments
Table 106. Capricor Therapeutics Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 107. Capricor Therapeutics Exosome Therapy Product Offered
Table 108. Capricor Therapeutics Main Business
Table 109. Capricor Therapeutics Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Capricor Therapeutics Latest Developments
Table 111. Stem Cell Medicine Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 112. Stem Cell Medicine Exosome Therapy Product Offered
Table 113. Stem Cell Medicine Main Business
Table 114. Stem Cell Medicine Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Stem Cell Medicine Latest Developments
Table 116. CellTex Therapeutics Details, Company Type, Exosome Therapy Area Served and Its Competitors
Table 117. CellTex Therapeutics Exosome Therapy Product Offered
Table 118. CellTex Therapeutics Main Business
Table 119. CellTex Therapeutics Exosome Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. CellTex Therapeutics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Exosome Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosome Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Exosome Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Exosome Therapy Sales Market Share by Country/Region (2022)
Figure 8. Exosome Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Exosome Therapy Market Size Market Share by Type in 2022
Figure 10. Exosome Therapy in Hospital
Figure 11. Global Exosome Therapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Exosome Therapy in Clinic
Figure 13. Global Exosome Therapy Market: Clinic (2018-2023) & ($ Millions)
Figure 14. Exosome Therapy in Research Institutions
Figure 15. Global Exosome Therapy Market: Research Institutions (2018-2023) & ($ Millions)
Figure 16. Global Exosome Therapy Market Size Market Share by Application in 2022
Figure 17. Global Exosome Therapy Revenue Market Share by Player in 2022
Figure 18. Global Exosome Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Exosome Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Exosome Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Exosome Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Exosome Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Exosome Therapy Value Market Share by Country in 2022
Figure 24. United States Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Exosome Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Exosome Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Exosome Therapy Market Size Market Share by Application in 2022
Figure 31. China Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Exosome Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Exosome Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Exosome Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Exosome Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Exosome Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Exosome Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Exosome Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Exosome Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Exosome Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Exosome Therapy Market Size Market Share Forecast by Application (2024-2029)